Table 1 Clinicopathologic features, treatment, and outcome of EGISTs reported in the English literature
From: Extra-gastrointestinal stromal tumor of the pancreas: case report and review of the literature
Author | Year | Age (years) | Sex | Site/Treatment | Size (cm) | Mitotic count (/50 HPF) | Follow-up, months |
|---|---|---|---|---|---|---|---|
Neto et al. [11] | 2004 | 67 | F | Body and tail/DP + Imatinib | 20 | 120; CD117(+) CD34(+) | A, Relapse, 1 |
Yamaura et al. [12] | 2004 | 54 | F | Tail/DP | 14 | Few; CD117(-) CD34(+) | A, NED, 30 |
Krska et al. [13] | 2005 | 38 | F | Body and tail/DP | 17 | 1; CD117(-) CD34(+) | A, NED, 30 |
Daum et al. [14] | 2005 | 70 | F | Head/PD + Imatinib | 10 | 2; CD117(+) CD34(-) | A, NED, 6 |
Showalter et al. [15] | 2008 | 72 | F | Tail/DP | 7 | 3; CD117(+) CD34(-) | A, NED, 27 |
Yan et al. [16] | 2008 | 47 | M | Uncinate process/NR | 2.4 | 3; CD117(+) CD34(-) | NA |
Yang et al. [17] | 2008 | 55 | M | Body and Tail/DP + Imatinib | NR | NR; CD117(+) CD34(+) | Relapse, 24,- A, NED,41 |
Harindhanavudhi et al. [18] | 2008 | 63 | F | Body/Cystojejunostomy + Imatinib | 16 | <5; CD117(+) CD34(+) | NA |
Trablesi et al. [19] | 2009 | 52 | F | Head/PD | 10.5 | 6; CD117(+) CD34(+) | A, NED, 10 |
Goh et al. [20] | 2009 | 58 | M | Head/PD | 9 | >10; CD117(+); CD34 (-) | A, NED, 60 |
Padhi et al. [21] | 2010 | 42 | F | Body and tail/DP | 35 | 6-8; CD117(+) CD34(+) | A, NED, 10 |
Saif et al. [22] | 2010 | 31 | M | Head/PD + Imatinib | 8 | 48; CD117(+) CD34(-) | A, Relapse, 9 |
Crisan et al. [23] | 2010 | 61 | M | Tail | 34 | NR | A, NED, 3 |
Joshi and Rustagi [24] | 2010 | 84 | M | Whole pancreas/NOP | 34 | NR; CD117(+) CD34(+) | Dead day 5 of admission |
Rao et al. [25] | 2011 | 40 | M | Head and body/PD + Imatinib | 6.5 | 8-10; CD117(+) CD34(+) | Relapse, 24; A, NED 30 |
Cecka et al. [26] | 2011 | 74 | F | Tail/DP | 11 | <5; CD117(+)CD34(+) | A, NED, 66 |
Vij et al. [27] | 2011 | 35 | M | Head/PD + Imatinib | 6.5 | 12-15; CD117(+) CD34(-) | Relapse, 24; A, NED 48 |
Soufi et al. [28] | 2012 | 39 | M | Head/PD + Imatinib | 9 | 5; CD117(+) CD34(+) | A, NED, 24 |
Kim et al. [29] | 2012 | 55 | M | Tail/DP + Imatinib | 15.8 | 7; CD117(+) CD34(-) | A, NED, 4 |
Babu et al. [30] | 2012 | 55 | F | Head/local resection | 5 | 6-8; CD117(+); CD34 (+) | A, NED, 11 |
Present case | 2013 | 63 | F | Uncinate process/enucleation | 2.4 | 1; CD117(+) | A, NED, 6 |